ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Clinical trial NCT07284667 · RECRUITING

Trial details

NCT number: NCT07284667
Sponsor: ACADIA Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)Depressive Disorder, Treatment-Resistant

Start date: 2025-11-14
Primary completion: 2027-08-01
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.